New vaccine for virus that causes respiratory disease approved for Singaporeans aged 60 and above
newsare.net
SINGAPORE - Singaporeans aged 60 and above can now get vaccinated against a contagious virus that causes respiratory tract infections and could lead to complications in older folk. The vaccine, called Arexvy, protects against the respiratory syncytial virusNew vaccine for virus that causes respiratory disease approved for Singaporeans aged 60 and above
SINGAPORE - Singaporeans aged 60 and above can now get vaccinated against a contagious virus that causes respiratory tract infections and could lead to complications in older folk. The vaccine, called Arexvy, protects against the respiratory syncytial virus (RSV), and was developed by British pharmaceutical giant GSK. The jab was approved by the Health Sciences Authority on May 10 and protects against lower respiratory tract disease caused by the contagious virus, which poses greater risks to older adults. The GSK vaccine is the first for the virus to be available in Singapore, and an application for its use for those who are between 50 and 59 is still under review, said HSA in response to queries. For Singaporeans 60 and older, the vaccine is available at some general practitioner and specialist clinics, said GSK in response to queries, but it did not disclose the list of clinics. Checks by The Straits Times found that several clinics charge between $320 and $350 for the vaccination, which comprises a single dose delivered by injection to a muscle. Read more